CRISPR NEWS

U.S. Patent and Trademark Office issued 4th CRISPR patent to CVC

On April 23, 2019, the U.S. Patent and Trademark Office issued U.S. Patent No. 10,266,850 (‘the ‘850 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier (collectively, “CVC”). The patent covers compositions and methods for modifying a target DNA molecule in any setting, including animal and human cells, as well as in vitro settings, that are widely used throughout the industry. Of note, the ‘850 patent had been examined previously and found allowable in advance of a prior, terminated interference proceeding involving the Broad Institute.

View Press Release

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
Read moreArrow-down